Sign in
Active, not recruitingNo phase

Comparison of Left Bundle Branch Area Versus Right Ventricular Septal Pacing in Patients With High-degree Conduction Disease After Transcatheter Aortic Valve Replacement (Left Bundle BRAVE)

Key facts

Who runs it
Main Line Health
Where
Overland Park, Philadelphia, Ridgewood, and Wynnewood, United StatesSee the 4 sites
Trial code
Status
Active, not recruiting
People taking part
46 people, planned
Started
28 Dec 2022
Ended
31 Dec 2025
Type of study
Interventional, 2 groups
Treatments tested
  • Right ventricular septal pacing followed by left bundle branch area pacing
  • Left bundle branch area pacing followed by right ventricular septal pacing
Record updated
10 December 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Subject has at least one of these conduction disturbances:; Symptomatic (or hemodynamically significant) bradycardia or symptomatic persistent atrioventricular block including first-degree and Mobitz I (Wenckebach) or Mobitz type II atrioventricular bock; High-grade atrioventricular block; Third-degree atrioventricular block
  • Subject has undergone TAVR (any valve system) in the last four weeks
  • Subject is receiving a first-time pacemaker implant
  • Subject's most recent documented ejection fraction (by any method) within the past 90 days prior to study enrollment is > 50% (≥45% if visually estimated at the time of enrollment)
  • Subject is a male or female at least 18 years old at the time of consent
  • Subject is able to receive a left sided pectoral implant

Who cannot take part

  • Subject has ever had a previous or has an existing implantable pulse generator (IPG), implantable cardiac defibrillator (ICD) or biventricular (BiV) implant
  • Subject is enrolled in a concurrent study that may confound the results of this study
  • Subject has a mechanical heart valve
  • Subject status post heart transplant
  • Subject has LVEF < 45% if visually estimated at the time of enrollment
  • Subject has more than mild para-valvular regurgitation following TAVR implantation
  • Subject is indicated for a biventricular pacing device (CRT-P or CRT-D)
  • Subject is pregnant, or of childbearing potential and not on a reliable form of birth control
  • Subject life expectancy less than 2 years

Where in United States

  • Kansas City Heart Rhythm InstituteOverland Park, United States
  • Hospital of the University of PennsylvaniaPhiladelphia, United States
  • Valley Health SystemRidgewood, United States
  • Lankenau Medical CenterWynnewood, United States

About the trial

What the trial wants to find out

The purpose of the study is to investigate the superiority of chronic left bundle branch area pacing compared to traditional right ventricular (RV) septal pacing in patients with high-grade conduction disease after transcatheter aortic valve replacement (TAVR). In this investigator initiated, multicenter, prospective, double-blinded, crossover study, chronic left bundle branch area pacing will be compared to chronic right ventricular septal pacing using echocardiographic measures of left ventricular systolic function in patients with a high cumulative ventricular pacing burden after TAVR.

The 2 groups in the trial

  • Group ATreatment being tested

    Treatment: Right ventricular septal pacing followed by left bundle branch area pacing

  • Group BTreatment being tested

    Treatment: Left bundle branch area pacing followed by right ventricular septal pacing

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparison of Left Bundle Branch Area Versus Right Ventricular Septal Pacing in Patients With High-degree Conduction Disease After Transcatheter Aortic Valve Replacement
Publications
Record updated
10 December 2024